Skanditek’s subsidiary CMA Microdialysis AB to implement new share issue totaling SEK 70 million
The Skanditek subsidiary CMA is implementing a private placement of new shares amounting to SEK 56 million. The new issue will be directed at Investor Growth Capital. Within a period of three years, CMA’s Board of Directors will have an opportunity to arrange an additional private placement aimed at Investor Growth Capital in an amount of SEK 14 million.For further information, see the appended press release from CMA Microdialysis AB or visit www.microdialysis.seCMA will hold an Extraordinary General Meeting on Thursday, October 16, 2008.Prior to the private placement, Skanditek’s